ETF DAILY NEWS

Q1 EPS Estimates for UroGen Pharma Lowered by HC Wainwright

UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for UroGen Pharma in a report issued on Tuesday, March 11th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.93) per share for the quarter, down from […]

Mar 15, 2025 - 06:39
 0
Q1 EPS Estimates for UroGen Pharma Lowered by HC Wainwright
UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for UroGen Pharma in a report issued on Tuesday, March 11th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of ($0.93) per share for the quarter, down from […]
Read More

Tags:

Previous Article

What is Lifesci Capital’s Forecast for TARA Q1 Earnings?

Next Article

Verona Pharma (NASDAQ:VRNA) Shares Gap Down Following Insider Selling

Related Posts

Q1 Earnings Estimate for LINC Issued By Barrington Research

Q1 Earnings Estimate for LINC Issued By Barrington Rese...

Mar 1, 2025  0

Robert W. Baird Increases AdaptHealth (NASDAQ:AHCO) Price Target to $16.00

Robert W. Baird Increases AdaptHealth (NASDAQ:AHCO) Pri...

Mar 1, 2025  0

Walt Disney (NYSE:DIS) Price Target Raised to $130.00 at Loop Capital

Walt Disney (NYSE:DIS) Price Target Raised to $130.00 a...

Mar 5, 2025  0